Cargando…

Hepatitis C Virus Infection: Looking for Interferon Free Regimens

Recent developments of new drugs' combinations are changing the treatment paradigm in hepatitis C virus infection. Due to the side effect profile of pegylated interferons, interferon-sparing regimens have become the main target in chronic hepatitis C treatment research. Recent proofs of concept...

Descripción completa

Detalles Bibliográficos
Autores principales:	González-Moreno, J., Payeras-Cifre, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654259/ https://www.ncbi.nlm.nih.gov/pubmed/23710151 http://dx.doi.org/10.1155/2013/825375

Ejemplares similares

Adherence to treatment of chronic hepatitis C: from interferon containing regimens to interferon and ribavirin free regimens
por: Younossi, Zobair M., et al.
Publicado: (2016)

Interferon-free regimens in patients with hepatitis C infection and renal dysfunction or kidney transplantation
por: Cholongitas, Evangelos, et al.
Publicado: (2017)

What Is New in Listeriosis?
por: Hernandez-Milian, Almudena, et al.
Publicado: (2014)

Modelling how responsiveness to interferon improves interferon-free treatment of hepatitis C virus infection
por: Venugopal, Vishnu, et al.
Publicado: (2018)

Interferon-Free Regimens and Direct-Acting Antiviral Agents for Delta Hepatitis: Are We There Yet?
por: Nemteanu, Roxana, et al.
Publicado: (2023)

Concise review: Interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infection
por: Weiler, Nina, et al.
Publicado: (2016)

Interferon-Free Treatments for Chronic Hepatitis C Genotype 1 Infection
por: FakhriRavari, Alireza, et al.
Publicado: (2016)

Interferon-free treatment for hepatitis C virus infection induces normalization of extrahepatic type I interferon signaling
por: Sung, Pil Soo, et al.
Publicado: (2018)

Successful Eradication of Hepatitis C Virus by Interferon-Free Regimens in Two Patients with Advanced Liver Fibrosis following Kidney Transplantation
por: Sasaki, Reina, et al.
Publicado: (2016)

Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection
por: Salama, Iman Ibrahim, et al.
Publicado: (2022)

The Role of Type III Interferons in Hepatitis C Virus Infection and Therapy
por: Bruening, Janina, et al.
Publicado: (2017)

Interferon-free combination therapies for the treatment of hepatitis C: current insights
por: Holmes, Jacinta A, et al.
Publicado: (2015)

Occult Infection with Hepatitis C Virus: Looking for Clear-Cut Boundaries and Methodological Consensus
por: Wróblewska, Anna, et al.
Publicado: (2021)

The New Era of Interferon-Free Treatment of Chronic Hepatitis C
por: Solbach, Philipp, et al.
Publicado: (2015)

Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals
por: Lee, Hye Won, et al.
Publicado: (2020)

Psychometric Validation of the Hepatitis C Symptom and Impact Questionnaire (HCV-SIQv4) in a Diverse Sample of Adults with Chronic Hepatitis C Virus Infection Treated with an Interferon-free Simeprevir-containing Regimen
por: Trigg, Andrew, et al.
Publicado: (2019)

Successful Treatment of Mixed Hepatitis C Genotypes in a Cirrhotic Patient With an All-Oral, Interferon-Free Regimen
por: Ahmed Sakr, Ayman, et al.
Publicado: (2017)

Superiority of Interferon-Free Regimens for Chronic Hepatitis C: The Effect on Health-Related Quality of Life and Work Productivity
por: Younossi, Zobair M., et al.
Publicado: (2017)

Autoimmune thyroid disorders in hepatitis C virus infection: Effect of interferon therapy
por: Jadali, Zohreh
Publicado: (2013)

Type III Interferons in Hepatitis C Virus Infection
por: Boisvert, Maude, et al.
Publicado: (2016)

Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection
por: Liu, Chen-Hua, et al.
Publicado: (2017)

Real World Experience of Chronic Hepatitis C Retreatment with Genotype Specific Regimens in Nonresponders to Previous Interferon-Free Therapy
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2019)

Role of viral and host factors in interferon based therapy of hepatitis C virus infection
por: Imran, Muhammad, et al.
Publicado: (2013)

Interferon Lambda 4 Polymorphism Predicts Sustained Viral Response in Hepatitis C Virus Patients Irrespective of Hepatitis C Virus Genotypes, Ethnicity or Treatment Regimen: Results From a Meta-Analysis
por: Wu, Qin, et al.
Publicado: (2015)

The Incidence of Hepatocellular Carcinoma Is not Increased in Individuals with Chronic Hepatitis C After Treatment with Interferon-free Regimens: an ERCHIVES Study
por: Li, Darrick K, et al.
Publicado: (2017)

Dimension of chronic hepatitis C virus in HIV-infected patients in the interferon-free era: an overview from south Spain
por: Rivero-Juarez, A., et al.
Publicado: (2015)

Pegylated Interferon and Ribavirin Treatment for Hepatitis C Virus Infection
por: Kagawa, Tatehiro, et al.
Publicado: (2010)

Achieving sustained virologic response after interferon‐free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosis
por: Meissner, E. G., et al.
Publicado: (2016)

Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infection
por: Wong, Mun-Teng, et al.
Publicado: (2016)

Rapid changes in peripheral lymphocyte concentrations during interferon‐free treatment of chronic hepatitis C virus infection
por: Meissner, Eric G., et al.
Publicado: (2017)

Interferon Response in Hepatitis C Virus (HCV) Infection: Lessons from Cell Culture Systems of HCV Infection
por: Sung, Pil Soo, et al.
Publicado: (2015)

Prioritization for interferon-free regimens and potential drug interactions of current direct-acting anti-hepatitis C agents in routine clinical practice
por: Papatheodoridi, Μargarita, et al.
Publicado: (2017)

Daclatasvir-based Treatment Regimens for Hepatitis C Virus Infection: A Systematic Review and Meta-Analysis
por: Alavian, Seyed Moayed, et al.
Publicado: (2016)

Direct-acting Antiviral Regimens for Patients with Chronic Infection of Hepatitis C Virus Genotype 3 in China
por: Wang, Xiaozhong, et al.
Publicado: (2021)

Randomized trial of interferon‐ and ribavirin‐free ombitasvir/paritaprevir/ritonavir in treatment‐experienced hepatitis C virus–infected patients
por: Chayama, Kazuaki, et al.
Publicado: (2015)

Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy
por: Urbanowicz, Arkadiusz, et al.
Publicado: (2018)

Interferon Response in Hepatitis C Virus-Infected Hepatocytes: Issues to Consider in the Era of Direct-Acting Antivirals
por: Sung, Pil Soo, et al.
Publicado: (2020)

Treatment of Hepatitis C Infections with Interferon: A Historical Perspective
por: Friedman, Robert M., et al.
Publicado: (2010)

Sofosbuvir/velpatasvir regimen promises an effective pan-genotypic hepatitis C virus cure
por: Mir, Fazia, et al.
Publicado: (2017)

Treatment of Adolescents With Chronic Hepatitis C Virus Infection: New Regimen on the Block
por: Indolfi, Giuseppe, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0nc105appturbsqbr128gpd64n